Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Femasys (FEMY) Shares Repurchased (2023 - 2025)

Femasys posted quarterly Shares Repurchased of $161761.0 for Q1 2025, up 572.13% year-on-year from $24067.0 in Q1 2024, and up 437.54% on a QoQ basis from $30093.0 in Q4 2024.

Femasys (FEMY) has 3 years of Shares Repurchased data on file, last reported at $161761.0 in Q1 2025.

  • For the quarter ending Q1 2025, Shares Repurchased rose 572.13% year-over-year to $161761.0; the trailing twelve-month figure through Mar 2025 stood at $198447.0 (down 21.88% YoY), and the FY2024 full-year result was $60753.0, down 73.58% from the prior year.
  • Shares Repurchased for Q1 2025 stood at $161761.0, up from $30093.0 in the prior quarter.
  • Across five years, Shares Repurchased topped out at $229953.0 in Q4 2023 and bottomed at $6593.0 in Q2 2024.
  • The 3-year median for Shares Repurchased is $30093.0 (2024), against an average of $90493.4.
  • The widest annual swing landed in 2024, when Shares Repurchased tumbled 86.91%; it then jumped 572.13% in 2025.
  • A 3-year view of Shares Repurchased shows it stood at $229953.0 in 2023, then sank by 86.91% to $30093.0 in 2024, then soared by 437.54% to $161761.0 in 2025.
  • The last three Shares Repurchased figures came in at $161761.0 (Q1 2025), $30093.0 (Q4 2024), and $6593.0 (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 1.12 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 2.00 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 175.01 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 297.60 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 67.00 Mn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 92.50 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 31.20 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 99.97 Mn
10 Femasys 22.30 Mn 16.91 Mn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2025 161,761.00
Mar 31, 2025 161,761.00
Dec 31, 2024 30,093.00
Dec 31, 2024 30,093.00
Jun 30, 2024 6,593.00
Jun 30, 2024 6,593.00
Mar 31, 2024 24,067.00
Mar 31, 2024 24,067.00
Dec 31, 2023 229,953.00
Dec 31, 2023 229,953.00